Methenamine Hippurate Brown & Burk Uk

Active Ingredient:: Methenamine Hippurate
Origin:: EU

Methenamine Hippurate Brown & Burk Uk (Methenamine Hippurate)

Q: What is Methenamine Hippurate used for?

Methenamine Hippurate is used as a urinary antiseptic to help prevent recurrent urinary tract infections, particularly in adults who experience frequent infections or require prophylaxis after urological procedures.

Q: How does methenamine hippurate work in the body?

The drug is hydrolysed in acidic urine to release formaldehyde, which has broad antibacterial activity. Formaldehyde disrupts bacterial proteins and nucleic acids, inhibiting the growth of uropathogens within the urinary tract.

Q: What is the usual dose of methenamine hippurate?

The appropriate dose of methenamine hippurate is determined by the prescribing clinician based on the patient’s condition, renal function, and urine pH. Dosage regimens should follow the prescriber’s instructions and local prescribing guidelines.

Q: Is methenamine hippurate safe during pregnancy or breastfeeding?

Safety data for methenamine hippurate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

Q: How do I order Methenamine Hippurate Brown & Burk Uk from GNH India?

Enquiries can be submitted on the product page at gnhindia.com by specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Q: How does methenamine hippurate compare with other urinary antiseptics?

Methenamine hippurate differs from antibiotics such as nitrofurantoin or trimethoprim because it is not an antimicrobial agent but a pro‑drug that generates formaldehyde in acidic urine. This mechanism provides a non‑antibiotic approach to prophylaxis, reducing the risk of bacterial resistance.

Q: What are the storage and handling requirements for methenamine hippurate?

The product should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the container tightly closed and out of reach of children.

Q: How is methenamine hippurate administered?

Methenamine hippurate is taken orally, usually as a tablet, with or without food as directed by the prescriber. Adequate fluid intake is recommended to maintain urine output and ensure proper drug activation in the urinary tract.

Q: What are the most serious risks associated with methenamine hippurate?

Serious risks, although rare, include acute interstitial nephritis, severe allergic reactions such as anaphylaxis, and hematuria. Patients should seek immediate medical attention if they experience signs of kidney inflammation, rash, swelling, or blood in the urine.

Q: Who should not use methenamine hippurate?

Methenamine hippurate should be avoided in patients with severe renal impairment, those with an inability to maintain acidic urine (e.g., chronic urinary alkalinisation), and individuals with known hypersensitivity to the drug or its components.

Methenamine hippurate, the active ingredient in Methenamine Hippurate Brown & Burk Uk, is a urinary antiseptic presented as an oral tablet for oral use. It is employed to prevent recurrent urinary tract infections in adult patients and is marketed in the European Union.

GNH India supplies Methenamine Hippurate Brown & Burk Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Manufacturer / TM Owner

Brown & Burk Uk Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Methenamine hippurate is used as a urinary antiseptic for the prevention of urinary tract infections.

Recurrent urinary tract infection: helps reduce the frequency of infections in adults.
Post‑operative urinary prophylaxis: used to lower infection risk after urological surgery.
Chronic catheterisation: may be employed to decrease infection incidence in patients with long‑term catheter use.

How It Works

In acidic urine (pH < 6.0), methenamine hippurate is hydrolysed to release formaldehyde and ammonia. The generated formaldehyde exerts broad‑spectrum antibacterial activity by denaturing bacterial proteins and nucleic acids, thereby inhibiting the growth of uropathogens within the urinary tract.

Side Effects

Methenamine hippurate may cause adverse reactions, most of which are mild and reversible.

Common Side Effects

Nausea: mild stomach upset.
Dyspepsia: indigestion or heartburn.
Metallic taste: transient alteration in taste.
Urine discoloration: darkening of urine.

Serious or Rare Side Effects

Acute interstitial nephritis: inflammation of kidney interstitium.
Severe allergic reaction: rash, swelling, or anaphylaxis.
Hematuria: blood in urine.

Precautions & Warnings

When prescribing methenamine hippurate, clinicians should consider several safety and handling precautions.

Acidic urine requirement: effectiveness depends on urine pH below 6.0.
Renal function: avoid in patients with severe renal impairment.
Hepatic disease: use with caution in significant liver disease.
Concomitant alkalinising agents: may reduce drug efficacy.
Pregnancy and lactation: safety not established; use only if clearly needed.
Store at ambient temperature: keep below 25 °C, retain in original container, protect from moisture.

Avoid Interactions

Methenamine hippurate can interact with other medicines, influencing its antibacterial activity or safety profile.

Major Interactions (Avoid)

Urine‑alkalinising agents (e.g., sodium bicarbonate, potassium citrate): raise urine pH and diminish drug activation.
Antacids containing magnesium or aluminum: may increase urinary pH and reduce efficacy.

Moderate Interactions (Monitor Closely)

Loop diuretics: may alter urinary concentration, affecting drug levels.
Renal toxicants (e.g., aminoglycosides): combined use may increase risk of kidney injury.
Anticoagulants: monitor INR as formaldehyde formation could theoretically affect clotting.

Frequently Asked Questions

Methenamine Hippurate is used as a urinary antiseptic to help prevent recurrent urinary tract infections, particularly in adults who experience frequent infections or require prophylaxis after urological procedures.

The drug is hydrolysed in acidic urine to release formaldehyde, which has broad antibacterial activity. Formaldehyde disrupts bacterial proteins and nucleic acids, inhibiting the growth of uropathogens within the urinary tract.

The appropriate dose of methenamine hippurate is determined by the prescribing clinician based on the patient’s condition, renal function, and urine pH. Dosage regimens should follow the prescriber’s instructions and local prescribing guidelines.

Safety data for methenamine hippurate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

Enquiries can be submitted on the product page at gnhindia.com by specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Methenamine hippurate differs from antibiotics such as nitrofurantoin or trimethoprim because it is not an antimicrobial agent but a pro‑drug that generates formaldehyde in acidic urine. This mechanism provides a non‑antibiotic approach to prophylaxis, reducing the risk of bacterial resistance.

The product should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the container tightly closed and out of reach of children.

Methenamine hippurate is taken orally, usually as a tablet, with or without food as directed by the prescriber. Adequate fluid intake is recommended to maintain urine output and ensure proper drug activation in the urinary tract.

Serious risks, although rare, include acute interstitial nephritis, severe allergic reactions such as anaphylaxis, and hematuria. Patients should seek immediate medical attention if they experience signs of kidney inflammation, rash, swelling, or blood in the urine.

Methenamine hippurate should be avoided in patients with severe renal impairment, those with an inability to maintain acidic urine (e.g., chronic urinary alkalinisation), and individuals with known hypersensitivity to the drug or its components.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 06 Sep 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.